Table 1 Antimicrobial susceptibility test among donors of KPC- 2 or -3, recipient and transconjugant
From: Plasmid transferability of KPC into a virulent K2 serotype Klebsiella pneumoniae
Antibiotics | Recipient K2 | Donor | Transconjugant | ||
|---|---|---|---|---|---|
| Â | Â | KPC-2 | KPC-3 | KPC-2 | KPC-3 |
Ampicillin | ≥32 | ≥32 | ≥32 | ≥32 | ≥32 |
Cefazolin | ≤2 | ≥32 | ≥32 | ≥32 | ≥32 |
Cefoxitin | ≤4 | ≥128 | ≥128 | ≥128 | ≥128 |
Aztreonam | ≤1 | ≥32 | ≥32 | ≥32 | ≥32 |
Cefotaxime | ≤1 | 32 | 32 | 8 | 8 |
Ceftazidime | ≤1 | ≥32 | ≥32 | ≥32 | ≥32 |
Cefepime | ≤1 | ≥32 | 16 | 16 | 8 |
Ertapenem | ≤0.25 | ≥8 | ≥8 | ≥8 | ≥8 |
Imipenem | 0.5 | ≥8 | ≥8 | ≥8 | ≥8 |
Meropenem | ≤0.25 | ≥8 | ≥8 | ≥8 | ≥8 |
Doripenem | ≤0.12 | ≥4 | ≥4 | ≥4 | ≥4 |
Colistin | 1 | ≤0.5 | ≥4 | ≤1 | 1 |
Tigecycline | ≤0.25 | 1 | ≤0.25 | ≤0.25 | ≤0.25 |
Gentamicin | ≤1 | ≤1 | ≥16 | ≤1 | ≤1 |
Amikacin | ≤4 | 16 | 32 | ≤4 | ≤4 |
Ciprofloxacin | 0.12 | ≥4 | ≥4 | ≤0.06 | 0.12 |
Levofloxacin | ≤0.5 | ≥8 | ≥8 | ≤0.5 | ≤0.5 |
SXT* | ≤0.5 | ≥4 | ≥4 | ≥4 | ≤0.5 |